ArticleNano letters2026
Stoichiometrically Defined Antibody-DNA Conjugates for Quantitative Super-Resolution Imaging.
Article in Nano letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
DNA-PAINT enables super-resolution imaging with molecular-scale precision and, through qPAINT analysis, quantitative determination of protein copy numbers. However, qPAINT accuracy critically depends on the stoichiometric definition of the DNA-antibody conjugate. Conventional amine-reactive labeling generates heterogeneous antibody populations carrying variable numbers of DNA docking strands, compromising quantitative reliability. Here, we introduce site-selective disulfide rebridging using pyridazinedione chemistry to generate stoichiometrically defined antibody-DNA conjugates with either one (OAR1) or four (OAR4) DNA-PAINT docking sequences per antibody. Using nuclear pore complexes as a benchmark, we demonstrate that both OAR1 and OAR4 probes yield narrow qPAINT index distributions that exhibit the expected proportional dependence on protein copy number, enabling reliable discrimination between singly and doubly labeled Nup96 dimers. In contrast, conventional lysine-based conjugation produces broadened distributions and systematic overestimation due to uncontrolled DNA loading. These results establish selective antibody-DNA conjugation as a prerequisite for accurate quantitative DNA-PAINT in complex cellular environments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.